Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results Webcast And Conference Call To November 2, 2012 Due

Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results 
Webcast And Conference Call To November 2, 2012 Due To Hurricane Sandy 
MONTREAL, Oct. 30, 2012 /CNW/ - Valeant Pharmaceuticals International, Inc. 
(NYSE: VRX) (TSX: VRX) today announced that it has decided to reschedule its 
webcast and conference call to discuss financial results for the 2012 third 
quarter, which was previously scheduled for Wednesday, October 31, 2012 at 8 
a.m. ET, due to the severe weather conditions and power outages associated 
with Hurricane Sandy. The webcast and conference call has been rescheduled for 
November 2, 2012 at 8 a.m. ET and the financial results will be issued at 6:00 
a.m. ET. 
The dial-in number to participate on this call is (877) 281-0402, confirmation 
code 39252322.  International callers should dial (631) 813-4869, confirmation 
code 39252322. A replay will be available approximately two hours following 
the conclusion of the conference call to Friday, November 9, 2012, and can be 
accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 
39252322. 
The webcast and slide presentation will be hosted in the investor relations 
section of its corporate Web site at www.valeant.com. Participants should 
allow approximately five to 10 minutes prior to the call's start time to visit 
the site and to download any streaming media software needed to listen to the 
Internet webcast. An online archive of the webcast will be available following 
the end of the live call in the webcast archive portion of the investor 
relations section at www.valeant.com. 
About Valeant 
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational 
specialty pharmaceutical company that develops, manufactures and markets a 
broad range of pharmaceutical products primarily in the areas of dermatology, 
neurology and branded generics.  More information about Valeant can be found 
at www.valeant.com. 
(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO) 
Contact Information: Laurie W. Little  949-461-6002  laurie.little@valeant.com 
http://www.valeant.com 
http://photos.prnewswire.com/prnh/20101025/LA87217LOGO 
PRN Photo Desk, photodesk@prnewswire.com 
SOURCE: Valeant Pharmaceuticals International, Inc. 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/October2012/30/c3255.html 
CO: Valeant Pharmaceuticals International, Inc.
ST: Quebec
NI: HEA MTC CONF  
-0- Oct/30/2012 15:08 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.